Ahlers James M bought CUE
July 30, 2026 · Form 4 insider transaction
Ahlers James M bought 51,000 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
51,000
Price
$0.00
Total value
N/A
InsiderAhlers James M
RoleOfficer
CompanyCue Biopharma, Inc. (CUE)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 30, 2026
Filing dateAugust 3, 2026
Shares owned after51,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option becomes exercisable in equal quarterly installments over four years from July 30, 2026, subject to the reporting person's continued service with the issuer through each vest date.